Document is current
Any future updates will be listed below
-
Authors
Graham, Laura
Banda, Kalyan
Torres, Alba
Carver, Brett S.
Chen, Yu
Pisano, Katie
Shelkey, Greg
Curley, Tracy
Scher, Howard I.
Lotan, Tamara L.
Hsieh, Andrew C.
Rathkopf, Dana E.
-
Funding
Funding for this research was provided by:
American Society of Clinical Oncology (n/a)
National Cancer Institute (T32CA009515, 1R01 CA182503-01A1, 1K08CA175154-01, P50CA092629, P30CA008748)
Congressionally Directed Medical Research Programs (W81XWH-12-PCRP-TIA)
V Foundation for Cancer Research (n/a)
American Association for Cancer Research (n/a)
Burroughs Wellcome Fund (n/a)
Millenium Pharmaceuticals (n/a)
Prostate Cancer Foundation (n/a)
- License Information
-
More Information
Article History
Received: 7 December 2017
Accepted: 15 February 2018
First Online: 6 March 2018
Compliance with ethical standards
:
: D.E.R. is a consultant for Janssen (uncompensated) and receives research funding from Astellas, Astra-Zeneca, Celgene, Genentech, Janssen, Medivation, Novartis, Taiho, Tracon. L.G. declares that she has no conflicts of interest. K.B. declares that he has no conflicts of interest. A.T. declares that she has no conflicts of interest. B.S.R. declares that he has no conflicts of interest., Y.C. declares that he has no conflicts of interest. K.P. declares that she has no conflicts of interest. G.S. declares that he has no conflicts of interest. H.I.S. declares that he has no conflicts of interest. T.L.L. declares that she has no conflicts of interest. A.C.H. declares that he has no conflicts of interest.
: Informed consent was obtained from all individual participants included in the study.
